The Trendlines' (SGX:42T) board approved investments in its portfolio companies by the related companies of Librae Holdings, according to a filing with the Singapore Exchange on Thursday.
Librae is a controlling shareholder of the company. Along with the company, Librae will invest in ProArc Medical and Sol Chip for a total of approximately $1.9 million.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.